FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40743111000001106: Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2314881000001114 Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2314891000001111 Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Is a Enfortumab vedotin 30mg powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Is a Padcev true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has specific active ingredient Enfortumab vedotin true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) 1 vial Has AMP True Padcev 30mg powder for concentrate for solution for infusion vials (Astellas Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start